In Brief: Advertising Regulation, Vansen Consumer, Star Scientific

Supplement firms’ claims referred to FDA, FTC; review prompts new script for Zvelt ads; Vansen starts consumer portfolio with Canadian deal; Star Scientific pivots to drug development; and more In Brief.

Council of Better Business Bureaus industry self-regulation arms referred to the Federal Trade Commission advertising by nutritional product marketers Elements of Health Care LLC and Natures Flava LLC after the firms failed to provide support for product claims. The Electronic Retailing Self-Regulation Program on March 18 said it also referred direct-response advertising for Sanford, Fla.-based Natures Flava’s Dinamo supplement, which made claims, including customer testimonials, for treating diabetes. The National Advertising Division on March 14 referred to FTC ad claims for Lindon, Utah-based Elements of Health Care’s L’Arginine Plus supplements, including “Sharper and improved memory, restful sleeping and morning alertness, increased metabolism, reduction in menopause and PMT symptoms and a whole range of other benefits have all been linked to L-arginine.” CBBB’s divisions refer cases to FTC and FDA when firms refuse to provide substantiating evidence for claims or fail to follow recommendations following reviews.

Progenum International LLC is changing advertising for its Zvelt “fat loss patch” based on the Electronic Retailing Self-Regulation Program’s review....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

UK HRA Sets Targets For Digital Overhaul, Trial Transparency And Trust

 
• By 

The UK Health Research Authority’s latest three-year strategy sets ambitious targets to make research more transparent. One World Health Organization official believes the authority can go further by setting equally high standards for the timely reporting of clinical trial results.

UK’s Plan To Become World’s Third Top Life Sciences Economy Falls Short, Says ABPI

 

The Association of the British Pharmaceutical Industry says that while the government’s newly published Life Sciences Sector Plan includes many positive commitments, they are not enough.

England Leads Europe In Reimbursing Vertex’s Next-In-Class CF Drug Alyftrek

 

Vertex said it reached “a broad reimbursement agreement” with the National Health Service for its once-daily, triple combination treatment for cystic fibrosis. As for reimbursement in the rest of Europe, the company is targeting Ireland, Denmark and Germany next.

UK HRA Working On ‘Trusted’ Path Forward To Support Simplified Informed Consent

 
• By 

The Health Research Authority is working on a streamlined model for informed consent that maintains people’s trust.

More from Europe

Valneva Expects UK And France to Lift Ixchiq Age Restriction Following EMA Decision

 

Other authorities are expected to mirror the European Medicines Agency’s decision to lift the temporary restriction it placed on using Valneva’s chikungunya vaccine in people aged 65 years and older.

UK’s Plan To Become World’s Third Top Life Sciences Economy Falls Short, Says ABPI

 

The Association of the British Pharmaceutical Industry says that while the government’s newly published Life Sciences Sector Plan includes many positive commitments, they are not enough.

EMA Sets New Priorities As Number Of RWE Studies Climbs 48%

 

Real-world data studies conducted by the European Medicines Agency increased by 48% according to its latest report on the topic, prompting the agency to consider how it can better integrate this type of evidence into regulatory decision-making.